Library / Laws / 118th Congress / House Bills / H.R. 1375
H.R. 1375
To allow the Secretary of Health and Human Services to deny approval of a new drug application for an opioid analgesic drug on the basis of such drug not being clinically superior to other commercially available drugs.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2023-03-03 | 1.1K | ⠃⠗⠋ |